[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-335782-105":59,"doc-detail-335782-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","copy-number-variations-contribute-to-malignant-tumor-development-in-children-with-serious-birth-defects","Copy Number Variations Contribute to Malignant Tumor Development in Children with Serious Birth Defects","","Copy number variations (CNVs) shape malignant tumor development in children with serious birth defects (BDs). Whole-genome sequencing of blood-derived DNA was performed on 1,556 individuals without chromosomal anomalies, including BD probands with malignant tumors, cancer-free BD children, and healthy controls, with CNV-focused analysis. About half of BD-cancer children carried CNVs absent from BD-only or healthy groups, and CNVs showed strong patient-to-patient heterogeneity. Functional enrichment highlighted recurrent pathway-level alterations, including neurological gene deletions and immune-response duplications, while phenotype clustering emphasized sarcoma recurrences and non-coding RNA regulators linked to growth and cancer regulation. The study supports shared biological processes underlying pediatric tumorigenesis in BDs.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/copy-number-variations-contribute-to-malignant-tumor-development-in-children-with-serious-birth-defects/335782/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/copy-number-variations-contribute-to-malignant-tumor-development-in-children-with-serious-birth-defects/335782.png","ImageObject",300,407,{"name":92,"@type":93},"Valentina","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What two key signatures of pediatric cancers does the article highlight?","Question",{"text":112,"@type":113},"The article highlights (a) a higher prevalence of germline alterations and (b) heterogeneity in alteration types among pediatric cancers.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was the study designed to evaluate copy number variations?",{"text":117,"@type":113},"Researchers performed whole-genome sequencing on blood-derived DNA from 1,556 individuals without chromosomal anomalies, including children with birth defects who had malignant tumors, birth-defect children without cancer, and healthy individuals, focusing on CNV analysis.",{"name":119,"@type":110,"acceptedAnswer":120},"What did the study find about CNVs in children with birth-defect-related cancers?",{"text":121,"@type":113},"Roughly half of BD-cancer children had CNVs not identified in BD-only or healthy groups, and CNVs were not evenly distributed, showing strong heterogeneity with limited recurrent cancer-predisposition genes across multiple patients.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},335782,1790035603,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":4},13056703020460,"https://ap-avatar.wpscdn.com/avatar/be000253dac470eee5d?_k=1778207105932848923","Copy number variations contribute to malignant tumor development in children with serious birth defects Yichuan Liu 1 , Joseph Glessner 1,2, Hui-Qi Qu 1, Xiao Chang 1, Haijun Qiu 1, Tiancheng Wang 1, Frank D. Mentch 1 and Hakon Hakonarson 1,2,3,4,5   \n1 Center for Applied Genomics (CAG), Children’s Hospital of Philadelphia, PA, USA  \n2 Department of Pediatrics, The Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA  \n3 Division of Human Genetics, Children’s Hospital of Philadelphia, PA, USA  \n4 Division of Pulmonary Medicine, Children’s Hospital of Philadelphia, PA, USA  \n5 Faculty of Medicine, University of Iceland, Reykjav 􀀁ık, Iceland  \nKeywords  \nbirth defects; copy number variations; pediatric cancers; whole-genome sequencing  \nCorrespondence  \nY. Liu and H. Hakonarson, Center for Applied Genomics (CAG), Children’s Hospital of Philadelphia, 3615 Civic Center Blvd, Abramson Building, Philadelphia, PA 19104, USA  \nFax: +1 267 426 0363 (HH)  \nTel: +1 215 882 0139; +1 267 426 0088 E-mail: [liuy5@email.chop.edu](liuy5@email.chop.edu); hakonarson@ [email.chop.edu](email.chop.edu)  \nYichuan Liu and Joseph Glessner contributed equally to this article.  \n(Received 1 March 2024, revised 1 July 2024, accepted 30 July 2024, available online 14 August 2024)  \ndoi:10 . 1002/1878-0261 .13718  \nThere are two key signatures of pediatric cancers: (a) higher prevalence of germline alterations and (b) heterogeneity in alteration types. Recent population-based assessments have demonstrated that children with birth defects (BDs) are more likely to develop cancer even without chromosomal anomalies; therefore, explorations of genetic alterations in children with BDsand cancers could provide new insights into the underlying mechanisms for pediatric tumor development. We performed whole-genome sequencing (WGS) on blood-derived DNA for 1556 individuals without chromosomal anomalies, including 454 BD probands with at least one type of malignant tumor, 757 cancer-free children with BDs, and 345 healthy individuals, focusing on copy number variation (CNV) analysis. Roughly half of the children with BD-cancer have CNVs that are not identiﬁed in BD-only/healthy individuals, and CNVs are not evenly distributed among these patients. Strong heterogeneity was observed, with a limited number of cancer predisposition genes containing CNVs in more than three patients. Moreover, functional enrichments of genes with CNVs showed that dozens of patients have variations related to the same biological pathways, such as deletions of genes with neurological functions and duplications of immune response genes. Phenotype clustering uncovered recurrences of patients with sarcoma: A notable enrichment was observed involving non-coding RNA regulators, showing strong signals related to growth and cancer regulations in functional analysis. In conclusion, we conducted one of the ﬁrst genomic studies exploring the impact of CNVs on cancer development in children with BDs, unveiling new insights into the underlying biological processes.  \n1. Introduction  \nPediatric cancers have fewer somatic mutations, but a higher prevalence of germline alterations compared to cancers in adults. Strong heterogeneity of the mutations plus limited genome proﬁling at diagnosis has halted  \nprogression of our understanding of the underlying mechanisms of malignant tumor development and progression in pediatric cancer patients [1] . It is well known that children with birth defects (BD) are more likely to  \nAbbreviations  \nBDs, birth defects; CAG, Center for Applied Genomics; CHOP, Children’s Hospital of Philadelphia; CNV, copy number variation; DRAGEN, Dynamic Read Analysis for GENomics; EMRs, electronic medical records; ICD code, International Classiﬁcation of Diseases code; LncRNAs, long non-coding RNAs; VCF, variant call format; WebGestalt, WEB-based Gene SeT AnaLysis Toolkit; WGS, whole-genome sequencing.  \nMolecular Oncology 19 (2025) 899–912 ª 2024 The Author(s) ","cbCaivqyLnnKdHtG","https://ap.wps.com/l/cbCaivqyLnnKdHtG","pdf",2250563,14,"English","# Key signatures and study rationale\n## CNVs in children with birth defects and pediatric cancer\n# Study design and cohorts\n## Whole-genome sequencing and CNV analysis\n# Main findings\n## Patient-level CNV heterogeneity\n## Functional enrichment and pathway recurrences\n## Phenotype clustering and sarcoma signals\n# Conclusion and implications","[{\"question\":\"What two key signatures of pediatric cancers does the article highlight?\",\"answer\":\"The article highlights (a) a higher prevalence of germline alterations and (b) heterogeneity in alteration types among pediatric cancers.\"},{\"question\":\"How was the study designed to evaluate copy number variations?\",\"answer\":\"Researchers performed whole-genome sequencing on blood-derived DNA from 1,556 individuals without chromosomal anomalies, including children with birth defects who had malignant tumors, birth-defect children without cancer, and healthy individuals, focusing on CNV analysis.\"},{\"question\":\"What did the study find about CNVs in children with birth-defect-related cancers?\",\"answer\":\"Roughly half of BD-cancer children had CNVs not identified in BD-only or healthy groups, and CNVs were not evenly distributed, showing strong heterogeneity with limited recurrent cancer-predisposition genes across multiple patients.\"}]","Copy Number Variations Contribute to Malignant Tumor Development in Children with Serious Birth Defects | PDF",1790012332,35]